FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a new ...

Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...

The Centers for Medicare & Medicaid Services (CMS) announced Thursday that its Innovation Center is launching a pair of 5-year demonstration projects aimed at evaluating different approaches to shared ...

New research from King's College London suggests that a rapid blood testing method could deliver reliable results far more quickly than previously thought, potentially supporting faster and more ...